Structure |
Chemical Name |
CAS |
MF |
![1-chloro-3-(dimethoxymethyl)benzene](/CAS/20180703/GIF/3395-80-0.gif) |
1-chloro-3-(dimethoxymethyl)benzene |
3395-80-0 |
C9H11ClO2 |
![N-(3-bromo-4-oxocyclohexyl)acetamide](/CAS/GIF/687639-03-8.gif) |
N-(3-bromo-4-oxocyclohexyl)acetamide |
687639-03-8 |
C8H12BrNO2 |
![methyl (Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate](/CAS/20180703/GIF/CB73116220.gif) |
methyl (Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C44H51N9O4 |
![Alvimopan Impurity 5](/) |
Alvimopan Impurity 5 |
|
|
![Palbociclib-d8](/CAS/20180808/GIF/1628752-83-9.gif) |
Palbociclib-d8 |
1628752-83-9 |
C24H21D8N7O2 |
![Ivabradine Impurity 15](/CAS/20200515/GIF/1132667-04-9.gif) |
Ivabradine Impurity 15 |
1132667-04-9 |
C12H17NO2 |
![Sofosbuvir Impurity27](/) |
Sofosbuvir Impurity27 |
|
|
![Isavuconazole Impurity 12](/) |
Isavuconazole Impurity 12 |
|
|
![Tacrolimus Impurity 3](/CAS/20211123/GIF/161861-10-5.gif) |
Tacrolimus Impurity 3 |
161861-10-5 |
C45H71NO13 |
![Bisoprolol EP Impurity J](/CAS/20180703/GIF/1797024-50-0.gif) |
Bisoprolol EP Impurity J |
1797024-50-0 |
C15H24O5 |
![Ceftriaxone Impurity](/CAS/20211123/GIF/79221-95-7.gif) |
Ceftriaxone Impurity |
79221-95-7 |
C18H18N8O8S3 |
![Betaxolol EP Impurity E](/CAS/20210111/GIF/1329613-85-5.gif) |
Betaxolol EP Impurity E |
1329613-85-5 |
C18H31NO3 |
![Tulobuterol Impurity](/CAS/20200611/GIF/34356-83-7.gif) |
Tulobuterol Impurity |
34356-83-7 |
C8H5Br2ClO |
![Olaparib Impurity A](/) |
Olaparib Impurity A |
|
|
![Dapoxetine Impurity 2](/) |
Dapoxetine Impurity 2 |
|
|
![Voriconazole Impurity 5](/) |
Voriconazole Impurity 5 |
|
|
![tetrahydrofuran-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate](/CAS/20180703/GIF/1404453-75-3.gif) |
tetrahydrofuran-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate |
1404453-75-3 |
C17H22O4 |
![Lamivudine impurity 5](/) |
Lamivudine impurity 5 |
|
|
![Clopidogrel Impurity 2](/CAS/20200401/GIF/CB73127503.gif) |
Clopidogrel Impurity 2 |
|
C15H14ClNO2S |
![Mirabegron Impurity 6](/CAS/20211123/GIF/2762802-64-0.gif) |
Mirabegron Impurity 6 |
2762802-64-0 |
C10H11ClN4O3S2 |
![Pitavastatin Impurity 3](/) |
Pitavastatin Impurity 3 |
|
|
![Solifenacin EP Impurity D](/) |
Solifenacin EP Impurity D |
|
|
![Cephalexin Impurity 2](/CAS/20200401/GIF/CB73127927.gif) |
Cephalexin Impurity 2 |
|
C16H17N3O4S |
![Cefuroxime Impurity 3](/CAS/20200401/GIF/CB73127932.gif) |
Cefuroxime Impurity 3 |
|
C16H16N4O8S |
![Vonoprazan Impurity 11](/) |
Vonoprazan Impurity 11 |
|
|
![Erlotinib Imp.14](/) |
Erlotinib Imp.14 |
|
|
![Sorafenib related compound 12](/CAS/20180808/GIF/284461-74-1.gif) |
Sorafenib related compound 12 |
284461-74-1 |
C20H14ClF3N4O3 |
![(1R,3S)-Solifenacin Succinate](/CAS/20180808/GIF/774517-20-3.gif) |
(1R,3S)-Solifenacin Succinate |
774517-20-3 |
C23H26N2O2 |
![Dacpomycin Impurity 2](/) |
Dacpomycin Impurity 2 |
|
|
![Nicorandil Impurity 3](/) |
Nicorandil Impurity 3 |
|
|
![Tacrolimus Impurity A](/) |
Tacrolimus Impurity A |
|
|
![1H-Benz[de]isoquinolin-1-one,2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-,(3aR)-](/CAS/20180703/GIF/135729-73-6.gif) |
1H-Benz[de]isoquinolin-1-one,2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-,(3aR)- |
135729-73-6 |
C19H24N2O |
![Mirabegron Impurity 19](/) |
Mirabegron Impurity 19 |
|
|
![(Z)-Mutagenic Impurity of Tenofovir Disoproxil](/CAS/20180703/GIF/1464851-21-5.gif) |
(Z)-Mutagenic Impurity of Tenofovir Disoproxil |
1464851-21-5 |
C8H9N5 |
![Moxifloxacin impurity (20)](/) |
Moxifloxacin impurity (20) |
|
|
![(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid](/CAS/20180703/GIF/112106-16-8.gif) |
(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid |
112106-16-8 |
C11H20O4 |
![Bazedoxifene impurity](/) |
Bazedoxifene impurity |
|
|
![Tamsulosin impurity](/CAS/20180703/GIF/CB73144881.gif) |
Tamsulosin impurity |
|
C20H28N2O5S |
![Clarithromycin (9Z)-Oxime](/CAS/20211123/GIF/127253-05-8.gif) |
Clarithromycin (9Z)-Oxime |
127253-05-8 |
C38H70N2O13 |
![N-Desmethyl Clarithromycin (9E)-Oxime](/CAS/20211123/GIF/127182-43-8.gif) |
N-Desmethyl Clarithromycin (9E)-Oxime |
127182-43-8 |
C37H68N2O13 |
![Ticagrelor Impurity 24](/CAS/20200611/GIF/1482484-92-3.gif) |
Ticagrelor Impurity 24 |
1482484-92-3 |
C7H11N3O2S |
![Moxifloxacin Impurity](/CAS/20180808/GIF/1797982-51-4.gif) |
Moxifloxacin Impurity |
1797982-51-4 |
C16H16FNO5 |
![sofosBuvir impurity 1](/) |
sofosBuvir impurity 1 |
|
|
![2-(3-cyano-4-isopropoxyphenyl)-4-methylthiazole-5-carboxylic acid](/CAS/20180703/GIF/144060-52-6.gif) |
2-(3-cyano-4-isopropoxyphenyl)-4-methylthiazole-5-carboxylic acid |
144060-52-6 |
C15H14N2O3S |
![R-Tirofiban](/CAS/20181212/GIF/158808-86-7.gif) |
R-Tirofiban |
158808-86-7 |
C22H36N2O5S |
![Canagliflozin Impurity 20](/) |
Canagliflozin Impurity 20 |
|
|
![Canagliflozin Impurity 6](/) |
Canagliflozin Impurity 6 |
|
|
![Carfilzomib Impurity 6](/) |
Carfilzomib Impurity 6 |
|
|
![Daclatasvir Impurity 5 (SRSS-Isomer)](/CAS/20211123/GIF/1009117-28-5.gif) |
Daclatasvir Impurity 5 (SRSS-Isomer) |
1009117-28-5 |
C40H50N8O6 |
![Dolutegravir Impurity 7](/CAS/20210305/GIF/2244161-71-3.gif) |
Dolutegravir Impurity 7 |
2244161-71-3 |
C20H21N3O5 |
![Istradefylline Impurity F](/) |
Istradefylline Impurity F |
|
|
![Linagliptin Impurity 22](/) |
Linagliptin Impurity 22 |
|
|
![Nintedanib impurity G](/CAS/20200515/GIF/894783-61-0.gif) |
Nintedanib impurity G |
894783-61-0 |
C30H31N5O4 |
![3,3′-[(2-methylbenzene-1,3-diyl)bis(oxy)]bis(N-methyl- 3-phenylpropan-1-amine)](/CAS/20211123/GIF/1010818-93-5.gif) |
3,3′-[(2-methylbenzene-1,3-diyl)bis(oxy)]bis(N-methyl- 3-phenylpropan-1-amine) |
1010818-93-5 |
C27H34N2O2 |
![Febuxostat impurity 36](/CAS/20210111/GIF/1805770-40-4.gif) |
Febuxostat impurity 36 |
1805770-40-4 |
C12H12N2O |
![N-[1-[(3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]- 2-Propenamide](/CAS/20180601/GIF/2031255-27-1.gif) |
N-[1-[(3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]- 2-Propenamide |
2031255-27-1 |
C28H26N6O3 |
![4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one](/CAS/20180703/GIF/CB73159061.gif) |
4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
|
C8H11FN3O4S- |
![Cephalexin Impurity 4](/CAS/20180703/GIF/CB73159223.gif) |
Cephalexin Impurity 4 |
|
C16H17N3O4S |
![Rivaroxaban Impurity 42](/) |
Rivaroxaban Impurity 42 |
|
|
![(R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoic acid](/CAS/20180601/GIF/1422514-05-3.gif) |
(R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoic acid |
1422514-05-3 |
C22H26FN3O6S |
![Cabozantinib Impurity C](/) |
Cabozantinib Impurity C |
|
|
![(3R,4R)-N,4-dimethyl-piperidin-3-amine](/CAS/20180601/GIF/1354469-76-3.gif) |
(3R,4R)-N,4-dimethyl-piperidin-3-amine |
1354469-76-3 |
C7H16N2 |
![4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine](/CAS/20180601/GIF/952518-97-7.gif) |
4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine |
952518-97-7 |
C9H7N5 |
![5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde](/CAS/20180601/GIF/881676-90-0.gif) |
5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde |
881676-90-0 |
C16H12N2O3S |
![3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4R)-](/CAS/20180601/GIF/100332-12-5.gif) |
3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4R)- |
100332-12-5 |
C13H18FNO |
![Pyridine, 4-chloro-2-(chloromethyl)-3-methyl-](/CAS/20180601/GIF/168167-48-4.gif) |
Pyridine, 4-chloro-2-(chloromethyl)-3-methyl- |
168167-48-4 |
C7H7Cl2N |
![1,2,4-Triazolo(3,4-b)benzothiazole-5-methanol](/CAS/20180601/GIF/69243-49-8.gif) |
1,2,4-Triazolo(3,4-b)benzothiazole-5-methanol |
69243-49-8 |
C9H7N3OS |
![Benzoicacid, 2-sulfino-](/CAS/20180601/GIF/13165-80-5.gif) |
Benzoicacid, 2-sulfino- |
13165-80-5 |
C7H6O4S |
![Benzenemethanamine, a-ethyl-N,N-dimethyl-](/CAS/20180601/GIF/3330-05-0.gif) |
Benzenemethanamine, a-ethyl-N,N-dimethyl- |
3330-05-0 |
C11H17N |
![CIS-1,2-BIS(AMINOMETHYL)CYCLOBUTANE](/CAS/20180601/GIF/15286-88-1.gif) |
CIS-1,2-BIS(AMINOMETHYL)CYCLOBUTANE |
15286-88-1 |
C6H14N2 |
![N-FORMYL-1-(2-AMINO-1-(4-METHOXYPHENYL)ETHYL)CYCLOHEXANOL](/StructureFile/ChemBookStructure8/GIF/CB7332100.gif) |
N-FORMYL-1-(2-AMINO-1-(4-METHOXYPHENYL)ETHYL)CYCLOHEXANOL |
272788-07-5 |
C16H23NO3 |
![Acotiamide Impurity](/CAS/20211123/GIF/198470-83-6.gif) |
Acotiamide Impurity |
198470-83-6 |
C20H21N2NaO4S |
![Terbutaline Impurity](/CAS/20200611/GIF/52144-90-8.gif) |
Terbutaline Impurity |
52144-90-8 |
C26H29NO3 |
![methyl (41S,12R,13aR)-13a-ethyl-12-
hydroxy-2,3,41,5,6,12,13,13aoctahydro-
1H-indolo[3,2,1-
de]pyrido[3,2,1-ij][1,5]naphthyridine-
12-carboxylate](/CAS/20210111/GIF/83508-83-2.gif) |
methyl (41S,12R,13aR)-13a-ethyl-12-
hydroxy-2,3,41,5,6,12,13,13aoctahydro-
1H-indolo[3,2,1-
de]pyrido[3,2,1-ij][1,5]naphthyridine-
12-carboxylate |
83508-83-2 |
C21H26N2O3 |
![ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate](/CAS/20180601/GIF/473465-11-1.gif) |
ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate |
473465-11-1 |
C18H18N2O3S |
![Ropivacaine-iPr-R](/CAS/20210111/GIF/1050482-18-2.gif) |
Ropivacaine-iPr-R |
1050482-18-2 |
C17H26N2O |
![Demiditraz IMpurity](/CAS/20211123/GIF/944268-66-0.gif) |
Demiditraz IMpurity |
944268-66-0 |
C20H22N2O |
![Betamethasone EP Impurity H](/CAS/20180601/GIF/185613-71-2.gif) |
Betamethasone EP Impurity H |
185613-71-2 |
C22H29FO5 |
![Blonanserin Impurity 10](/CAS/20210111/GIF/132810-87-8.gif) |
Blonanserin Impurity 10 |
132810-87-8 |
C23H30ClN3 |
![Blonanserin impurity G](/) |
Blonanserin impurity G |
|
|
![Cefodizime Impurity 5](/) |
Cefodizime Impurity 5 |
|
|
![Clindamycin Impurity 4](/) |
Clindamycin Impurity 4 |
|
|
![Doxofylline Impurity 4](/CAS/20200611/GIF/2095554-12-2.gif) |
Doxofylline Impurity 4 |
2095554-12-2 |
C11H16N4O5 |
![Eltrombopag Impurity 1](/CAS/20180906/GIF/1246929-02-1.gif) |
Eltrombopag Impurity 1 |
1246929-02-1 |
C25H23N5O3 |
![Everolimus impurity A](/) |
Everolimus impurity A |
|
|
![Fosaprepitant Impurity 13](/) |
Fosaprepitant Impurity 13 |
|
|
![Gefitinib Impurity J](/) |
Gefitinib Impurity J |
|
|
![Isavuconazole Impurity 23](/) |
Isavuconazole Impurity 23 |
|
|
![Isavuconazole Impurity 29](/) |
Isavuconazole Impurity 29 |
|
|
![Isavuconazole Impurity 7](/) |
Isavuconazole Impurity 7 |
|
|
![Lercanidipine Impurity 6](/CAS/20210111/GIF/786625-22-7.gif) |
Lercanidipine Impurity 6 |
786625-22-7 |
C37H43N3O6 |
![Linagliptin Impurity 43](/) |
Linagliptin Impurity 43 |
|
|
![MiraBegron Impurity A](/) |
MiraBegron Impurity A |
|
|
![Moxifloxacin Impurity 15](/) |
Moxifloxacin Impurity 15 |
|
|
![Moxifloxacin Impurity 32](/) |
Moxifloxacin Impurity 32 |
|
|
![Nifedipine Impurity F](/CAS/20180601/GIF/53055-15-5.gif) |
Nifedipine Impurity F |
53055-15-5 |
C18H20N2O6 |
![Olaparib Impurity 15](/CAS/20210111/GIF/2250243-17-3.gif) |
Olaparib Impurity 15 |
2250243-17-3 |
C24H25FN4O3 |
![Olopatadine Impurity 4](/CAS/20211123/GIF/55690-15-8.gif) |
Olopatadine Impurity 4 |
55690-15-8 |
C18H18O5 |
![Posaconazole Impurity 26](/) |
Posaconazole Impurity 26 |
|
|
![Posaconazole Impurity 48](/CAS/20210111/GIF/1902954-03-3.gif) |
Posaconazole Impurity 48 |
1902954-03-3 |
C37H42F2N8O5 |